R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014

dc.creatorBessa, Theolis Costa Barbosa
dc.creatorAragão, Erika Santos de
dc.creatorGuimarães, Jane Mary Medeiros
dc.creatorAlmeida, Bethânia de Araújo
dc.date2018-02-26T18:46:41Z
dc.date2018-02-26T18:46:41Z
dc.date2017
dc.date.accessioned2023-09-26T20:12:19Z
dc.date.available2023-09-26T20:12:19Z
dc.identifierBESSA, T. C. B. et al. R&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014. BioMed Research International, ID 4765719, 2017.
dc.identifier2314-6133
dc.identifierhttps://www.arca.fiocruz.br/handle/icict/24949
dc.identifier10.1155/2017/4765719
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8851305
dc.descriptionNational Institute of Science and Technology of Innovation onDiseases of Neglected Populations (INCT-IDPN),
dc.descriptionBased on an exploratory case study regarding the types of institutions funding the research and development to obtain new tuberculosis vaccines, this article intends to provoke discussion regarding the provision of new vaccines targeting neglected disease. Although our findings and discussion are mainly relevant to the case presented here, some aspects are more generally applicable, especially regarding the dynamics of development in vaccines to prevent neglected diseases. Taking into account the dynamics of innovation currently seen at work in the vaccine sector, a highly concentrated market dominated by few multinational pharmaceutical companies, we feel that global PDP models can play an important role throughout the vaccine development cycle. In addition, the authors call attention to issues surrounding the coordination of actors and resources in the research, development, manufacturing, and distribution processes of vaccine products arising from PDP involvement.
dc.formatapplication/pdf
dc.languageeng
dc.publisherHindawi Publishing Corporation
dc.rightsopen access
dc.subjectDoenças negligenciadas
dc.subjectTuberculose
dc.subjectVacinas contra a tuberculose
dc.subjectPesquisa
dc.subjectEnsaios clínicos como assunto
dc.subjectNeglected Diseases
dc.subjectTuberculosis
dc.subjectTuberculosis Vaccines
dc.subjectResearch
dc.subjectClinical trials as subject
dc.titleR&D in Vaccines Targeting Neglected Diseases: An Exploratory Case Study Considering Funding for Preventive Tuberculosis Vaccine Development from 2007 to 2014
dc.typeArticle


Este ítem pertenece a la siguiente institución